Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm still here...holding strong since .40's and .60's...just picked up some BIOF @ .90 too for good measure...
C you at $2.50, then $3.75, and when Valero decides to pull the trigger, I'll pull mine at $9.86...how's that?!
Do what?
I hear you...but inevitably if I want to dump what I got I have to adjust for cost since E*trade doesn't automatically do it - it seems. to add insult to injury they chrged me $20 for the restructuring.
I guess I need to manually go in and adjust the price paid?
Im showing .20 a share up 66,000%%%%%%%????????
OK....WTF??? The ihub 6mo line chart shows the sideways line in June with a huge spike in early July and my 6 month chart on E*Trade is not like that at all.
Now I feel stupid but still wondering WTF??? Is the ihub chart wrong, misleading, bogus?
indeed...
What do you think of todays news?
Looking back at the 6 month chart can someone explain the flatline in June and the sharp rise in July? What was that all about?
And apparently Brazil consumes a lot of it
See...this is the kind of post I just don't understand. I don't know about yours, but in MY world there are no ALTRUISTS. Saying you got out but that you hope it goes to $20 for me and everybody else is very nice, but uttery ridiculous. Why don't you want it to go to $20 for yourself??????? Are you allergic to making money???
DAY #2 - Closed over $1.00
YES!!! Me too...and caught IMMORTALS in 3-D. So nice to come home to this GLTA!
hmmm...hasn't moved much in an hour. These email blasts and stock alerts that are being sent out dont seem to be having too much effect on the volume today.
Ok because I'm kind of regretting the 300,000 shares I got yesterday @ .0048
.0035 x .0046
nobody wants to comment?
Day #1 - Closed over $1.00
Gonna post this count everyday until it's relisted. ok?
LMFAO...love your posts dude...so original!
Radient Pharmaceuticals Announces FY 2011 Third Quarter Results
Nov 14, 2011 13:43:00 (ET)
TUSTIN, Calif., Nov. 14, 2011 /PRNewswire via COMTEX/ -- Radient Pharmaceuticals Corporation (otcqx:RXPC) (otcpk:RXPC), a developer and marketer of In Vitro Diagnostic (IVD) cancer tests, today announced financial results for its third quarter ended September 30, 2011.
Revenues for the third quarter ended September 30, 2011 were $102,238 as compared to $34,446 for the quarter ended September 30, 2010. For the nine months ended September 30, 2011, revenues were $257,609, as compared to $116,840 for the nine months ended September 30, 2010. Loss from operations for the three months ended September 30, 2011 was $1,801,713, as compared to $2,338,665 for the three months ended September 30, 2010. The $536,952 (approximately 23%) decrease in our losses from operations was primarily due to an increase in sales combined with a decrease in selling, general and administrative expenses and research and development expenses.
Similarly, loss from operations for the nine months ended September 30, 2011 was $5,620,761, as compared to a loss of $6,705,359 in the nine months ended September 30, 2010. The $1,084,598 (approximately 16%) decrease in loss from operations was primarily due to an increase in sales combined with a decrease in selling, general and administrative expenses and research and development expenses.
Net income for the three months ended September 30, 2011 was $1,947,075 or a basic and diluted income of $0.01 per common share. Net income included a gain of $12,312,333 from the change in fair value of derivative instruments. Net loss for the same period in 2010 was $11,946,784 or a basic and diluted loss of $0.39 per common share.
For the nine months ended September 30, 2011 the net loss was $39,417,159 or a basic and diluted loss of $0.24 per common share, as compared to a net loss of $38,420,688 or a basic and diluted loss per common shares of $1.38. The increase in net loss is attributed to higher interest expense, legal settlement expenses, loss of guarantee and a loss on extinguishment of debt, offset by a gain on change in fair value of derivative liabilities. The complete filing is available at www.sec.gov .
"We continue to work to significantly increase revenues, subject to adequate funding for marketing efforts, with outreach to healthcare professionals and negotiations for additional distribution agreements in key international markets. Our Onko-Sure® IVD cancer diagnostic test kit, a simple, non-invasive blood test, has shown internationally to be effective in monitoring and detecting solid cancer tumors by measuring a specific breakdown product in the blood. Nineteen different types of cancer have been identified with the test," said Douglas MacLellan, Chairman and CEO.
The following table is intended to provide the latest information on Radient's business metrics.
Radient's Business Metrics
---------------------------------------------
Cash on hand: $103,000*
*Approximate amount as of November 11, 2011
---------------------------------------------
Common Shares Outstanding: 746 million*
*Approximate number as of November 11, 2011.
5 billion shares authorized.
---------------------------------------------
Outstanding Warrants & Options: 110 million*
*Approximate number as of November 11, 2011
---------------------------------------------
About Radient Pharmaceuticals:
Headquartered in Tustin, California, Radient Pharmaceuticals Corporation is dedicated to saving lives and money for patients and global healthcare systems through the deployment of its FDA-cleared In Vitro Diagnostic Onko-Sure® cancer test kit for colorectal cancer treatment and recurrence monitoring. The Company's focus is on the discovery, development and commercialization of unique high-value diagnostic tests that will help physicians answer important clinical questions related to early disease state detection, treatment strategy, and the monitoring of disease progression or recurrence. To learn more about our company, products, and potentially life-saving cancer test, visit www.radient-pharma.com .
Forward-Looking Statements:
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to Radient Pharmaceuticals Corporation, except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.
Paul KnopickE & E Communications949.707.5365pknopick@eandecommunications.com
SOURCE Radient Pharmaceuticals Corporation
Nevermind...just executed!
Ambac Inching Closer To Settlement With IRS Over Taxes -Sources
Nov 14, 2011 14:36:10 (ET)
By Joseph Checkler
Of DOW JONES DAILY BANKRUPTCY REVIEW
NEW YORK (Dow Jones)--Ambac Financial Group Inc. (ABKFQ) is moving closer to a settlement with the Internal Revenue Service over possible tax liabilities that contributed to the bond insurer's Chapter 11 bankruptcy filing last year and wants court permission to give creditors more time to digest the details of any such settlement, according to people familiar with the matter.
In a Friday letter to Judge Shelley C. Chapman of U.S. Bankruptcy Court in Manhattan, Ambac lawyer Peter A. Ivanick said any settlement with the IRS would necessitate giving creditors more time to vote on whether to accept or reject the company's bankruptcy exit plan, "out of an abundance of caution."
"The debtor intends to submit to the Department of Justice, Tax Division, a proposal to settle such dispute which includes terms that the debtor believes will be acceptable to the United States," wrote Ivanick of Dewey & LeBoeuf LLP.
While the people familiar with the matter told Dow Jones that Ambac and the IRS are "close" to striking a deal over what may be tax liabilities valued at over $800 million, two people said it's unclear whether a settlement would be within a few days or a few weeks. Any deal would also have to be approved by the Wisconsin Office of the Commissioner of Insurance, which is in control of Ambac's operating arm.
The IRS dispute casts a cloud over everything Ambac does in bankruptcy court: The IRS has claimed that Ambac owes it $807.2 million in taxes and interest stemming from what it called improper accounting.
Ambac has said that the accounting was proper and it doesn't owe money for the taxes.
An Ambac spokesman declined to comment on the settlement talks, as did a Justice Department spokeswoman. Late last month, Ambac lawyers told Chapman that significant progress had already been made in settling the dispute.
On Thursday, Ambac will ask Chapman to push back until Jan. 4, 2012, the date until which creditors can vote on its reorganization plan from the Nov. 23 deadline currently in place. Ambac hopes to have the plan, which would cede control of the company to bondholders and wipe out existing equity holders, confirmed by the court on Jan. 19.
Last November, the Wisconsin insurance regulator issued an injunction that essentially protected Ambac's possible tax liabilities as part of a plan that placed in a segregated account about $68 billion of an Ambac insurance subsidiary's policies.
The IRS fought that decision, saying it should be a federal issue, but a federal judge disagreed and sent it back to state court. Then, earlier this year, a state court approved the injunction as part of a larger rehabilitation plan for Ambac Assurance.
Originally an insurer of municipal bonds, Ambac sold guarantees on billions of dollars of mortgage-backed securities and more complex vehicles known as collateralized debt obligations, or CDOs. When the housing meltdown hit, many of these securities turned toxic, leaving Ambac with heavy losses.
When it filed for bankruptcy last November, Ambac cited the possible tax liabilities. In the opening days of its bankruptcy proceedings, Ambac struck a temporary pact with the IRS requiring the agency give notice to Ambac before seeking to recover any money.
(Dow Jones Daily Bankruptcy Review covers news about distressed companies and those under bankruptcy protection.)
-By Joseph Checkler, Dow Jones Daily Bankruptcy Review; 212-416-2152; joseph.checkler@dowjones.com
(END) Dow Jones Newswires
November 14, 2011 14:36 ET (19:36 GMT)
Hey...look at that! Thanks buddy!
So that's me @ .0048 :))) Should I go up the .0002?
Anyone have L2 they can post?
Thanks
So can someone please explain what is going on? My E*Trade account now displays 1,133 shares of this POS with a price paid of $0.00.
In the past where I've held something that did a R/S I had to manually go in and edit the price paid to reflect the new share price. Do I have to do this again????
How do you know they paid 110K for promo?
Anybody loading more here??? I've got my .004's
Here it comes!!!
Not usually the type to be confrontational but....STILL THINK IT'S A SCAM???????
No Kidding!!!
Anybody see the movie "WATERBOY"? When this goes over $1.00 I'm going to envision the farmer with the overalls. If you've seen the movie you know what I'm talking about...LMFAO
Well...maybe not WB but weren't people discussing BG owning some of this stock?
You may have just been saying that to make a point and maybe I'm crazy but I'm thinking PEIX is much better to be in than IBM.
PEIX is debt free...is IBM?
PEIX produces something that is both environmentally friendly and in demand...does IBM?
PEIX is on the way up from all time lows...is IBM?
PEIX could even be a target for a company like Exxon or HESS to buy them out for major $$$...is IBM being bought anytime soon?
Very exciting times for PEIX...IMO
"YOU MUST ALWAYS BE PREPARED ON A PUMP AND DUMP SITUATION WHERE ANYTHING IS POSSIBLE. THE ONLY GUARANTEE IS DEATH AND TAXES. I DO FEEL 1.00 POSSIBLE VERY SOON WITH 1.50 MAYBE BY THE END OF NOV. BUT UNDERSTAND EVERYTHING COULD COLLAPSE IN THE MATTER OF DAYS YOUR ARE NOT DEALING WITH IBM HEAR!!!!!!! "
Can you be more specific and explain how this will affect SAPX's PPS? Thanks...
"I was also told, that there is at least one group that is accumulating a significant amount of the float...
750k plus..float estimate please note EST
4 million "
Shoot...I could apply and be hired for that position easy!
Yea!!! I was going to say...I felt like that article was WRONG as I was reading it. Thanks for calling it out!
Besides being written on the upper left of that chart...how does one arrive at that 50dma number?
Impressive...400% when that happens...
So why "flip" there? Surely you don't think this is not going to go to at least double that return?
Aa I starting to sound piggish??? Or do you see something I don't???
Nope...personally I believe in this company, in what it's doing, and where it's doing it ...so I've been holding long on this GDPOS!!!
...it's just that I AM NEW TO IHUB and I've been making some more money through the many boards here and I'm starting to loose my patience with MINE.
"I was also told, that there is at least one group that is accumulating a significant amount of the float..."
HUH???????????
Yea me too a little only at .83 :(